Peapack Gladstone Financial Corp Amgen Inc Transaction History

Peapack Gladstone Financial Corp

$6.94 Billion
Q3 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 115,846 shares of AMGN stock, worth $30.5 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

115,846

Previous 115,873 0.02%

Holding current value

$30.5 Million

Previous $36.2 Million 3.1%

% of portfolio

0.54%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 26, 2024	SELL	$309.38 - $337.38 $8,353 - $9,109	-27 Reduced 0.02%	115,846 $37.3 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $588,560 - $715,254	2,240 Added 1.97%	115,873 $36.2 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $1.11 Million - $1.33 Million	4,112 Added 3.75%	113,633 $32.3 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $80,034 - $90,287	313 Added 0.29%	109,521 $31.5 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $167,704 - $208,209	767 Added 0.71%	109,208 $29.4 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $3.35 Million - $3.96 Million	15,625 Added 16.83%	108,441 $24.1 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $1.27 Million - $1.55 Million	-5,616 Reduced 5.71%	92,816 $22.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $790,611 - $1 Million	3,452 Added 3.63%	98,432 $25.9 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $2 Million - $2.26 Million	8,932 Added 10.38%	94,980 $21.4 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $1.77 Million - $1.97 Million	7,689 Added 9.81%	86,048 $20.9 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $442,267 - $489,263	2,017 Added 2.64%	78,359 $18.9 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $354,801 - $406,038	1,784 Added 2.39%	76,342 $17.2 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $171,514 - $200,949	808 Added 1.1%	74,558 $15.9 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $7,941 - $8,810	-34 Reduced 0.05%	73,750 $18 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $1.13 Million - $1.31 Million	5,085 Added 7.4%	73,784 $18.4 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $322,838 - $384,443	1,492 Added 2.22%	68,699 $15.8 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $672,272 - $747,621	2,865 Added 4.45%	67,207 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $284,450 - $349,060	1,438 Added 2.29%	64,342 $15.2 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $630,550 - $836,282	-3,460 Reduced 5.21%	62,904 $12.8 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $238,783 - $306,918	-1,262 Reduced 1.87%	66,364 $16 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $50,317 - $60,291	-289 Reduced 0.43%	67,626 $13.1 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $173,034 - $202,835	-1,038 Reduced 1.51%	67,915 $12.5 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $160,612 - $181,045	-888 Reduced 1.27%	68,953 $13.1 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $19,445 - $22,699	109 Added 0.16%	69,841 $13.6 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $201,039 - $226,645	1,085 Added 1.58%	69,732 $14.5 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $42,342 - $47,560	-255 Reduced 0.37%	68,647 $12.7 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $41,510 - $48,510	245 Added 0.36%	68,902 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $45,066 - $50,353	267 Added 0.39%	68,657 $0
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $56,878 - $64,940	-340 Reduced 0.49%	68,390 $0
Q2 2017 Aug 14, 2017	BUY	N/A	68,730	68,730 $0

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Amgen Inc Transaction History